Pediatric Skin Disease Frequencies and Dermatology Use by Race and Ethnicity in US Children's Hospitals

Nicolas G Quan1, Elizabeth Garcia-Creighton1, Molly Thapar1

  • 1Department of Dermatology, University of Colorado, Aurora.

JAMA Dermatology
|May 6, 2026
PubMed

Insights

Black children experience high rates of common skin conditions like atopic dermatitis (AD) and acne but have lower dermatology care use. Further research is needed to understand these disparities in pediatric specialty care access.

Area of Science:

  • Pediatric dermatology
  • Health disparities
  • Epidemiology

Background:

  • Understanding pediatric skin disease prevalence and specialty care access is crucial.
  • Patterns of disease frequency and care utilization vary by race and ethnicity.

Purpose of the Study:

  • To determine the frequency of common pediatric skin diseases.
  • To analyze dermatology care use patterns stratified by race and ethnicity.
  • To examine disparities in care across 8 US children's hospitals.

Main Methods:

  • Multicenter cross-sectional study using PEDSnet data (2009-2022).
  • Cohort included children with atopic dermatitis (AD), acne, infantile hemangioma, psoriasis, or hidradenitis suppurativa (HS).
  • Analyzed disease frequency per 100,000 children and dermatology care proportions by race/ethnicity.

Main Results:

  • Black children showed higher frequencies of AD, acne, and HS compared to White children.
  • Despite high disease burden, Black children had a lower proportion of dermatology care use across all studied conditions.
  • Significant variations in disease frequency and care utilization were observed across racial and ethnic groups.

Conclusions:

  • Black children face significant disparities in dermatology care access, with lower utilization despite higher disease prevalence.
  • These findings highlight potential gaps in specialty care for pediatric skin conditions.
  • Further investigation is warranted to address these inequities in pediatric healthcare.
Abstract

Related Concept Videos

Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
3.6K
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.4K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
562
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
414
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
417